The introduction of the 750mcg teriparatide product in Australia has encountered restricted sales . Currently, this higher dose form is largely designated for individuals with severe osteoporosis who have not improved with other therapies . Obtaining can be complex due to healthcare provider approval processes and restricted dispensary distribut… Read More